A STUDY OF TESTIS CANCER DURING 10 YEARS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MAHDAVI R.; TAGHAVI RAHIM; RAHMANI M.M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Medical Journal of Mashhad University of Medical Sciences Year:2003 | Volume:46 | Issue:80 Page(s): 53-58

Download Full-Text

Persian Verion

View:

6,793

Download:

Cites:

Information Journal Paper

Title

A STUDY OF TESTIS CANCER DURING 10 YEARS

Author(s)

MAHDAVI R. | TAGHAVI RAHIM | RAHMANI M.M. | Issue Writer Certificate

Keywords

TESTIS CANCERQ4

SURVIVALQ3

SEMINOMAQ4

NON-SEMINOMAQ4

Abstract

TESTIS CANCER is a relatively rare cancer in men. Because TESTIS CANCER has not studied since long time ago in Mashad University of Medical Sciences, this study was performed. In our study TESTIS CANCER made 1.8% of all cancers in men. In this study 96 patient with TESTIS CANCER followed up. The peak incidence age of for SEMINOMA was 20-40 years and for NON-SEMINOMA 20-30 years. In 66.5% of patients tumor was in right side and 33.5% in left. 14% of patients was cryptorchide. In 9% tumor developed in cryptorchide testis and in 5% in contralateral testis, the average delay time from beginning of symptoms was 6 months. In our patients 91.5% of SEMINOMAs were classic and 9.5% anaplastic. Tow year SURVIVAL in patient with testis tumor was 77% (89% in SEMINOMA and 62% in NON-SEMINOMA). Five year SURVIVAL in our patients was 69% (77% in SEMINOMA and 60% in NON-SEMINOMA). The best result of therapy found in patients with NON-SEMINOMA who got RPLND (with 2 years SURVIVAL of 100% and 5 year SURVIVAL of 85%). This result may'be too low due to high stage of disease at the time of diagnosis.

Cites

No record.

References

No record.

Cite

APA: Copy

MAHDAVI, R., TAGHAVI, RAHIM, & RAHMANI, M.M.. (2003). A STUDY OF TESTIS CANCER DURING 10 YEARS. MEDICAL JOURNAL OF MASHHAD UNIVERSITY OF MEDICAL SCIENCES, 46(80), 53-58. SID. https://sid.ir/paper/52291/en

Vancouver: Copy

MAHDAVI R., TAGHAVI RAHIM, RAHMANI M.M.. A STUDY OF TESTIS CANCER DURING 10 YEARS. MEDICAL JOURNAL OF MASHHAD UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2003;46(80):53-58. Available from: https://sid.ir/paper/52291/en

IEEE: Copy

R. MAHDAVI, RAHIM TAGHAVI, and M.M. RAHMANI, “A STUDY OF TESTIS CANCER DURING 10 YEARS,” MEDICAL JOURNAL OF MASHHAD UNIVERSITY OF MEDICAL SCIENCES, vol. 46, no. 80, pp. 53–58, 2003, [Online]. Available: https://sid.ir/paper/52291/en

Related Journal Papers